$AMRZ

BofA downgraded Amrize (NYSE:AMRZ) to Underperform, cutting its price target to $40 from $50. The firm cited growth concerns, including risks to U.S. cement prices, Canada macro conditions, and hurricane season impacts. Amrize's stock is down 30% year-to-date, trading at $37.25. Other analysts have also adjusted their price targets and ratings.

Amrize Ltd's average stock price target was reduced from $52.37 to $52.04 by 24 analysts, with a range of $40 to $65. This implies a 39% upside from the September 30 closing price. The consensus rating remains 'Buy' among 28 analysts.

Barclays initiated coverage on Amrize Ltd (NYSE:AMRZ) with an Equalweight rating and a $55 price target. The stock trades at $37.39, near its 52-week low. Barclays cited lower U.S. aggregates exposure and near-term challenges. Multiple analysts have adjusted price targets and ratings, citing weak earnings and cost pressures.

Oppenheimer kept its Outperform rating on Amrize, setting a $55 price target, suggesting a 44% upside from the recent $38.19 close. The firm cited Amrize's strong market position in North American construction, particularly in data centers, and its growth prospects driven by capacity enhancements and M&A.

Amrize (SWX:AMRZ) appointed Mario Gross as President of its Building Envelope division following Jake Gosa's resignation. The company's shares trade at CHF32.07, down 15.3% over the past month and 28.5% over the last quarter. Analysts suggest a fair value of CHF46.66, citing potential earnings power and margin expansion from the ASPIRE synergy program. The P/E ratio is 17.3x, compared to an estimated fair ratio of 30.5x and a peer average of 48.6x.

Amrize Ltd (NYSE: AMRZ) appointed Mario Gross as President of Building Envelope, effective September 11, 2026. Gross succeeds Jake Gosa and previously served as Chief Supply Chain Officer. Amrize reported $11.8 billion in revenue for 2025.

Amrize Ltd (AMRZ) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 Media Release Amrize Appoints Mario Gross as President of Building Envelope CHICAGO & ZUG, Switzerland, September 11, 2026 – The Amrize (NYSE: AMRZ) Board of Directors has appointed Mario Gross as President, Building Envelope, effective September 11, 2026. Gross succ

Boston Scientific (BSX) CEO Michael Mahoney bought 186,240 shares at $48.33 each, investing $9M. Shares fell 50% from $109.50 high, despite 7.5% sales growth. Cardinal Infrastructure Group (CDNL) execs bought shares totaling $4.5M after a 60% drop. GBank Financial Holdings (GBFH) CEO and others bought $1.74M in shares after a 50% decline. Amrize (AMRZ) CFO made purchases as shares fell 35% from highs.

Wells Fargo downgraded Amrize (AMRZ) to Equal Weight, lowering its price target to $44 from $55. The firm cited a cautious 2027 outlook due to reduced government spending and higher interest rates, expecting organic volume declines. This follows similar downgrades in the construction materials sector.

Wells Fargo's Timna Tanners downgraded Vulcan Materials (VMC) to Underweight, cutting the target to $254. BMO's John McNulty downgraded Westlake (WLK) to Market Perform, reducing the target to $82. Tanners also downgraded Amrize (AMRZ) and Eagle Materials (EXP), lowering their targets to $44 and $196, respectively.